시장조사 보고서 : 세계의 정신 장애 치료약 시장예측 2021년-2026년

■ 영문 제목 : Global Mental Disorders Drugs Market Growth 2021-2026
	■ 상품코드 : LPI-2108K201578 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 139 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦4,941,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,411,500	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦9,882,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 정신 장애 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (정신분열증 치료제, 항우울제, 항정신병제, 항불안제, 약물 및 알코올 중독 치료제, 소아 및 청소년 정신 질환 치료제, 인지 장애 치료제, 수면 장애, 기타)와 용도별 시장규모 (어린이, 청소년, 성인) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 정신 장애 치료약 시장 점유율
- 지역별 정신 장애 치료약 시장규모
- 주요지역의 종류별 시장규모 (정신분열증 치료제, 항우울제, 항정신병제, 항불안제, 약물 및 알코올 중독 치료제, 소아 및 청소년 정신 질환 치료제, 인지 장애 치료제, 수면 장애, 기타)
- 주요지역의 용도별 시장규모 (어린이, 청소년, 성인)
- 미주의 정신 장애 치료약 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 정신 장애 치료약 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 정신 장애 치료약 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 정신 장애 치료약 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 정신 장애 치료약 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Mental Disorders Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Mental Disorders Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Children
Adolescents
Adults

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Johnson and Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mental Disorders Drugs Consumption 2016-2026
2.1.2 Mental Disorders Drugs Consumption CAGR by Region
2.2 Mental Disorders Drugs Segment by Type
2.2.1 Drugs for Schizophrenia
2.2.2 Antidepressants
2.2.3 Antipsychotics
2.2.4 Anxiolytics
2.2.5 Drugs for the Treatment of Substance and Alcohol Addiction
2.2.6 Drugs for Childhood and Adolescent Mental Illness
2.2.7 Drugs to Treat Cognitive Disorders
2.2.8 Sleep Disorders
2.2.9 Others
2.3 Mental Disorders Drugs Sales by Type
2.3.1 Global Mental Disorders Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Mental Disorders Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Mental Disorders Drugs Sale Price by Type (2016-2021)
2.4 Mental Disorders Drugs Segment by Application
2.4.1 Children
2.4.2 Adolescents
2.4.3 Adults
2.5 Mental Disorders Drugs Sales by Application
2.5.1 Global Mental Disorders Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Mental Disorders Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Mental Disorders Drugs Sale Price by Application (2016-2021)

3 Global Mental Disorders Drugs by Company
3.1 Global Mental Disorders Drugs Sales Market Share by Company
3.1.1 Global Mental Disorders Drugs Sales by Company (2019-2021)
3.1.2 Global Mental Disorders Drugs Sales Market Share by Company (2019-2021)
3.2 Global Mental Disorders Drugs Revenue Market Share by Company
3.2.1 Global Mental Disorders Drugs Revenue by Company (2019-2021)
3.2.2 Global Mental Disorders Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Mental Disorders Drugs Sale Price by Company
3.4 Global Manufacturers Mental Disorders Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mental Disorders Drugs Product Location Distribution
3.4.2 Players Mental Disorders Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Mental Disorders Drugs by Region
4.1 Global Mental Disorders Drugs by Region
4.1.1 Global Mental Disorders Drugs Sales by Region
4.1.2 Global Mental Disorders Drugs Revenue by Region
4.2 Americas Mental Disorders Drugs Sales Growth
4.3 APAC Mental Disorders Drugs Sales Growth
4.4 Europe Mental Disorders Drugs Sales Growth
4.5 Middle East & Africa Mental Disorders Drugs Sales Growth

5 Americas
5.1 Americas Mental Disorders Drugs Sales by Country
5.1.1 Americas Mental Disorders Drugs Sales by Country (2016-2021)
5.1.2 Americas Mental Disorders Drugs Revenue by Country (2016-2021)
5.2 Americas Mental Disorders Drugs Sales by Type
5.3 Americas Mental Disorders Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Mental Disorders Drugs Sales by Region
6.1.1 APAC Mental Disorders Drugs Sales by Region (2016-2021)
6.1.2 APAC Mental Disorders Drugs Revenue by Region (2016-2021)
6.2 APAC Mental Disorders Drugs Sales by Type
6.3 APAC Mental Disorders Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Mental Disorders Drugs by Country
7.1.1 Europe Mental Disorders Drugs Sales by Country (2016-2021)
7.1.2 Europe Mental Disorders Drugs Revenue by Country (2016-2021)
7.2 Europe Mental Disorders Drugs Sales by Type
7.3 Europe Mental Disorders Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Mental Disorders Drugs by Country
8.1.1 Middle East & Africa Mental Disorders Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Mental Disorders Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Mental Disorders Drugs Sales by Type
8.3 Middle East & Africa Mental Disorders Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Mental Disorders Drugs Distributors
10.3 Mental Disorders Drugs Customer

11 Global Mental Disorders Drugs Market Forecast
11.1 Global Mental Disorders Drugs Forecast by Region
11.1.1 Global Mental Disorders Drugs Forecast by Regions (2021-2026)
11.2.2 Global Mental Disorders Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Mental Disorders Drugs Forecast by Type
11.7 Global Mental Disorders Drugs Forecast by Application

12 Key Players Analysis
12.1 Johnson and Johnson
12.1.1 Johnson and Johnson Johnson and Johnson Company Information
12.1.2 Johnson and Johnson Mental Disorders Drugs Product Offered
12.1.3 Johnson and Johnson Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Johnson and Johnson Main Business Overview
12.1.5 Johnson and Johnson Latest Developments
12.2 Pfizer
12.2.1 Pfizer Company Information
12.2.2 Pfizer Mental Disorders Drugs Product Offered
12.2.3 Pfizer Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Pfizer Main Business Overview
12.2.5 Pfizer Latest Developments
12.3 Eli Lilly
12.3.1 Eli Lilly Company Information
12.3.2 Eli Lilly Mental Disorders Drugs Product Offered
12.3.3 Eli Lilly Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Eli Lilly Main Business Overview
12.3.5 Eli Lilly Latest Developments
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Company Information
12.4.2 GlaxoSmithKline Mental Disorders Drugs Product Offered
12.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 GlaxoSmithKline Main Business Overview
12.4.5 GlaxoSmithKline Latest Developments
12.5 AstraZeneca
12.5.1 AstraZeneca Company Information
12.5.2 AstraZeneca Mental Disorders Drugs Product Offered
12.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 AstraZeneca Main Business Overview
12.5.5 AstraZeneca Latest Developments
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Company Information
12.6.2 Bristol-Myers Squibb Mental Disorders Drugs Product Offered
12.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Bristol-Myers Squibb Main Business Overview
12.6.5 Bristol-Myers Squibb Latest Developments
…

13 Research Findings and Conclusion

List of Tables
Table 1. Mental Disorders Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Drugs for Schizophrenia
Table 3. Major Players of Antidepressants
Table 4. Major Players of Antipsychotics
Table 5. Major Players of Anxiolytics
Table 6. Major Players of Drugs for the Treatment of Substance and Alcohol Addiction
Table 7. Major Players of Drugs for Childhood and Adolescent Mental Illness
Table 8. Major Players of Drugs to Treat Cognitive Disorders
Table 9. Major Players of Sleep Disorders
Table 10. Major Players of Others
Table 11. Global Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 12. Global Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 13. Global Mental Disorders Drugs Revenue by Type (2016-2021) & ($ million)
Table 14. Global Mental Disorders Drugs Revenue Market Share by Type (2016-2021)
Table 15. Global Mental Disorders Drugs Sale Price by Type (2016-2021)
Table 16. Global Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 17. Global Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 18. Global Mental Disorders Drugs Value by Application (2016-2021)
Table 19. Global Mental Disorders Drugs Revenue Market Share by Application (2016-2021)
Table 20. Global Mental Disorders Drugs Sale Price by Application (2016-2021)
Table 21. Global Mental Disorders Drugs Sales by Company (2019-2021) & (K Units)
Table 22. Global Mental Disorders Drugs Sales Market Share by Company (2019-2021)
Table 23. Global Mental Disorders Drugs Revenue by Company (2019-2021) ($ Millions)
Table 24. Global Mental Disorders Drugs Revenue Market Share by Company (2019-2021)
Table 25. Global Mental Disorders Drugs Sale Price by Company (2019-2021)
Table 26. Key Manufacturers Mental Disorders Drugs Producing Area Distribution and Sales Area
Table 27. Players Mental Disorders Drugs Products Offered
Table 28. Mental Disorders Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Mental Disorders Drugs Sales by Region (2016-2021) (K Units)
Table 32. Global Mental Disorders Drugs Sales Market Share by Region (2016-2021)
Table 33. Global Mental Disorders Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 34. Global Mental Disorders Drugs Revenue Market Share by Region (2016-2021)
Table 35. Americas Mental Disorders Drugs Sales by Country (2016-2021) & (K Units)
Table 36. Americas Mental Disorders Drugs Sales Market Share by Country (2016-2021)
Table 37. Americas Mental Disorders Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 38. Americas Mental Disorders Drugs Revenue Market Share by Country (2016-2021)
Table 39. Americas Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 40. Americas Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 41. Americas Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 42. Americas Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 43. APAC Mental Disorders Drugs Sales by Region (2016-2021) & (K Units)
Table 44. APAC Mental Disorders Drugs Sales Market Share by Region (2016-2021)
Table 45. APAC Mental Disorders Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 46. APAC Mental Disorders Drugs Revenue Market Share by Region (2016-2021)
Table 47. APAC Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 48. APAC Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 49. APAC Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 50. APAC Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 51. Europe Mental Disorders Drugs Sales by Country (2016-2021) & (K Units)
Table 52. Europe Mental Disorders Drugs Sales Market Share by Country (2016-2021)
Table 53. Europe Mental Disorders Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 54. Europe Mental Disorders Drugs Revenue Market Share by Country (2016-2021)
Table 55. Europe Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 56. Europe Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 57. Europe Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 58. Europe Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 59. Middle East & Africa Mental Disorders Drugs Sales by Country (2016-2021) & (K Units)
Table 60. Middle East & Africa Mental Disorders Drugs Sales Market Share by Country (2016-2021)
Table 61. Middle East & Africa Mental Disorders Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 62. Middle East & Africa Mental Disorders Drugs Revenue Market Share by Country (2016-2021)
Table 63. Middle East & Africa Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 64. Middle East & Africa Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 65. Middle East & Africa Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 66. Middle East & Africa Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 67. Global Mental Disorders Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 68. Global Mental Disorders Drugs Sales Market Share Forecast by Type (2021-2026)
Table 69. Global Mental Disorders Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 70. Global Mental Disorders Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 71. Global Mental Disorders Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 72. Global Mental Disorders Drugs Sales Market Share Forecast by Application (2021-2026)
Table 73. Global Mental Disorders Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 74. Global Mental Disorders Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 75. Johnson and Johnson Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 76. Johnson and Johnson Mental Disorders Drugs Product Offered
Table 77. Johnson and Johnson Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 78. Johnson and Johnson Main Business
Table 79. Johnson and Johnson Latest Developments
Table 80. Pfizer Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Mental Disorders Drugs Product Offered
Table 82. Pfizer Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Eli Lilly Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Eli Lilly Mental Disorders Drugs Product Offered
Table 87. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 88. Eli Lilly Main Business
Table 89. Eli Lilly Latest Developments
Table 90. GlaxoSmithKline Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. GlaxoSmithKline Mental Disorders Drugs Product Offered
Table 92. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 93. GlaxoSmithKline Main Business
Table 94. GlaxoSmithKline Latest Developments
Table 95. AstraZeneca Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. AstraZeneca Mental Disorders Drugs Product Offered
Table 97. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 98. AstraZeneca Main Business
Table 99. AstraZeneca Latest Developments
Table 100. Bristol-Myers Squibb Basic Information, Mental Disorders Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Bristol-Myers Squibb Mental Disorders Drugs Product Offered
Table 102. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 103. Bristol-Myers Squibb Main Business
Table 104. Bristol-Myers Squibb Latest Developments
List of Figures
Figure 1. Picture of Mental Disorders Drugs
Figure 2. Mental Disorders Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mental Disorders Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Mental Disorders Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Mental Disorders Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Drugs for Schizophrenia
Figure 10. Product Picture of Antidepressants
Figure 11. Product Picture of Antipsychotics
Figure 12. Product Picture of Anxiolytics
Figure 13. Product Picture of Drugs for the Treatment of Substance and Alcohol Addiction
Figure 14. Product Picture of Drugs for Childhood and Adolescent Mental Illness
Figure 15. Product Picture of Drugs to Treat Cognitive Disorders
Figure 16. Product Picture of Sleep Disorders
Figure 17. Product Picture of Others
Figure 18. Global Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 19. Global Mental Disorders Drugs Revenue Market Share by Type (2016-2021)
Figure 20. Mental Disorders Drugs Consumed in Children
Figure 21. Global Mental Disorders Drugs Market: Children (2016-2021) & (K Units)
Figure 22. Mental Disorders Drugs Consumed in Adolescents
Figure 23. Global Mental Disorders Drugs Market: Adolescents (2016-2021) & (K Units)
Figure 24. Mental Disorders Drugs Consumed in Adults
Figure 25. Global Mental Disorders Drugs Market: Adults (2016-2021) & (K Units)
Figure 26. Global Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Figure 27. Global Mental Disorders Drugs Revenue Market Share by Application in 2020
Figure 28. Global Mental Disorders Drugs Revenue Market by Company in 2020 ($ Million)
Figure 29. Global Mental Disorders Drugs Revenue Market Share by Company in 2020
Figure 30. Global Mental Disorders Drugs Sales Market Share by Regions (2016-2021)
Figure 31. Global Mental Disorders Drugs Revenue Market Share by Region in 2020
Figure 32. Americas Mental Disorders Drugs Sales 2016-2021 (K Units)
Figure 33. Americas Mental Disorders Drugs Revenue 2016-2021 ($ Millions)
Figure 34. APAC Mental Disorders Drugs Sales 2016-2021 (K Units)
Figure 35. APAC Mental Disorders Drugs Revenue 2016-2021 ($ Millions)
Figure 36. Europe Mental Disorders Drugs Sales 2016-2021 (K Units)
Figure 37. Europe Mental Disorders Drugs Revenue 2016-2021 ($ Millions)
Figure 38. Middle East & Africa Mental Disorders Drugs Sales 2016-2021 (K Units)
Figure 39. Middle East & Africa Mental Disorders Drugs Revenue 2016-2021 ($ Millions)
Figure 40. Americas Mental Disorders Drugs Sales Market Share by Country in 2020
Figure 41. Americas Mental Disorders Drugs Revenue Market Share by Country in 2020
Figure 42. Americas Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 43. Americas Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 44. United States Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Canada Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Mexico Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Brazil Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. APAC Mental Disorders Drugs Sales Market Share by Region in 2020
Figure 49. APAC Mental Disorders Drugs Revenue Market Share by Regions in 2020
Figure 50. APAC Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 51. APAC Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 52. China Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Japan Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Korea Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. Southeast Asia Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. India Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Australia Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. Europe Mental Disorders Drugs Sales Market Share by Country in 2020
Figure 59. Europe Mental Disorders Drugs Revenue Market Share by Country in 2020
Figure 60. Europe Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 61. Europe Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 62. Germany Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. France Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. UK Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Italy Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Russia Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Middle East & Africa Mental Disorders Drugs Sales Market Share by Country in 2020
Figure 68. Middle East & Africa Mental Disorders Drugs Revenue Market Share by Country in 2020
Figure 69. Middle East & Africa Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 70. Middle East & Africa Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 71. Egypt Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. South Africa Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. Israel Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. Turkey Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. GCC Country Mental Disorders Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles

※본 조사보고서 [세계의 정신 장애 치료약 시장예측 2021년-2026년] (코드 : LPI-2108K201578) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 정신 장애 치료약 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 양극성 장애 약물 시장예측 2021년-2026년
LPI-2108K202119 / LP Information / 2021년 8월 / 본 조사보고서는 양극성 장애 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 당뇨병 치료약 시장예측 2021년-2026년
LPI-2108K202104 / LP Information / 2021년 8월 / 본 조사보고서는 당뇨병 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 항우울제 시장예측 2021년-2026년
LPI-2108K202103 / LP Information / 2021년 8월 / 본 조사보고서는 항우울제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Antidepressant Drugs will have significant change from previous year. By the most conservative estimates of global Antidepressant Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 12180 million in 2019. Over...

세계의 생물학적 치료제 시장예측 2021년-2026년
LPI-2108K202118 / LP Information / 2021년 8월 / 본 조사보고서는 생물학적 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Biologic Therapeutics Drugs will have significant change from previous year. By the most conservative estimates of global Biologic Therapeutics Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 315410 million in...

세계의 고지혈증 처방약 시장예측 2021년-2026년
LPI-2108K201466 / LP Information / 2021년 8월 / 본 조사보고서는 고지혈증 처방약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Hyperlipidemia Prescription Drugs will have significant change from previous year. By the most conservative estimates of global Hyperlipidemia Prescription Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 입술 포진용 치료약 시장예측 2021년-2026년
LPI-2108K200023 / LP Information / 2021년 8월 / 본 조사보고서는 입술 포진용 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Herpes Labialis Drugs will have significant change from previous year. By the most conservative estimates of global Herpes Labialis Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항비만약 시장예측 2021년-2026년
LPI-2108K200019 / LP Information / 2021년 8월 / 본 조사보고서는 항비만약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 감량 치료제 시장예측 2021년-2026년
LPI-2108K200004 / LP Information / 2021년 8월 / 본 조사보고서는 감량 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Weight Loss Drugs will have significant change from previous year. By the most conservative estimates of global Weight Loss Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 동물용 통증 관리약 시장예측 2021년-2026년
LPI-2108K201967 / LP Information / 2021년 8월 / 본 조사보고서는 동물용 통증 관리약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Veterinary Pain Management Drugs will have significant change from previous year. By the most conservative estimates of global Veterinary Pain Management Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 항소화성 궤양 치료약 시장예측 2021년-2026년
LPI-2108K201064 / LP Information / 2021년 8월 / 본 조사보고서는 항소화성 궤양 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...